Hybio Pharmaceutical Cash Flow Reinvestment Rate
Hybio Pharmaceutical cash flow reinvestment rate. Hybio Pharmaceutical (300199) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting CN¥95.60 Million (capex CN¥95.60 Million ) from operating cash flow of CN¥117.78 Million. See Hybio Pharmaceutical (300199) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hybio Pharmaceutical (2007–2024)
Cash flow reinvestment rate of Hybio Pharmaceutical from 2007 to 2024. Historical reinvestment intensity for Hybio Pharmaceutical across 17 annual periods. Explore debt repayment capacity of Hybio Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Hybio Pharmaceutical Cash Flow Reinvestment Rate by Year (2007–2024)
Hybio Pharmaceutical cash flow reinvestment rate by year from 2007 to 2024. Year-by-year capital reinvestment analysis for Hybio Pharmaceutical. For the full cash flow conversion analysis, see cash flow conversion of Hybio Pharmaceutical.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥116.14 Million | CN¥164.71 Million | CN¥115.84 Million | ▼ -97.1% |
| 2022 | 24.36x | CN¥385.14 Million | CN¥15.81 Million | CN¥189.85 Million | ▲ +1635.3% |
| 2021 | 1.40x | CN¥220.20 Million | CN¥156.83 Million | CN¥199.00 Million | ▼ -73.9% |
| 2020 | 5.39x | CN¥258.66 Million | CN¥47.99 Million | CN¥243.66 Million | ▼ -7.0% |
| 2019 | 5.80x | CN¥606.40 Million | CN¥104.64 Million | CN¥570.15 Million | ▼ -36.0% |
| 2018 | 9.06x | CN¥425.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▲ +771.3% |
| 2017 | 1.04x | CN¥222.14 Million | CN¥213.74 Million | CN¥221.14 Million | ▲ +133.7% |
| 2016 | 0.44x | CN¥131.80 Million | CN¥296.41 Million | CN¥116.05 Million | ▼ -94.5% |
| 2015 | 8.09x | CN¥1.12 Billion | CN¥138.84 Million | CN¥358.98 Million | ▲ +1358.1% |
| 2014 | 0.56x | CN¥85.16 Million | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥302.85 Million | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥221.38 Million | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥78.27 Million | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥22.83 Million | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥9.01 Million | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥60.28 Million | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥4.90 Million | CN¥49.04 Million | CN¥4.90 Million | — |